DaVita and its former CEO acquitted of U.S. antitrust prices By Reuters

(Reuters) -A jury in Denver, Colorado, acquitted dialysis supplier DaVita (NYSE:) and its former CEO Kent Thiry on Friday of prices that they conspired with opponents to not rent one another’s staff.

The Justice Division had alleged within the case that each DaVita and Surgical Care Associates LLC required senior-level staff who sought to work for them to inform their present employers that they had been job-hunting.

“The jury affirmed that this case ought to by no means have been introduced,” Thiry stated in an announcement. “I wish to thank the group that supplied a lot help via this tough time.”

In an announcement, DaVita stated: “(We) are grateful to place this matter behind us. We stay dedicated to working with integrity and upholding the very best requirements of regulation.”

Whereas enforcers have historically targeted on costs and innovation in imposing antitrust regulation, the Biden administration has shifted its emphasis considerably to place extra deal with unlawful agreements that may push down wages.

Friday’s determination comes after DaVita and Thiry had an alleged anti-poaching settlement with Surgical Care Associates LLC, now a part of UnitedHealthcare, from 2012 to 2017 that sought to forestall every firm from wooing away senior-level staff, the Justice Division stated final yr.

SCA was charged in early 2021. Trial has been set for early subsequent yr.

The division additionally alleged that DaVita struck agreements with two different firms, Hazel Well being Inc and Radiology Companions, to not rent DaVita staff.

The jury acquitted the corporate and its former CEO on all three counts, a spokeswoman for Thiry stated.

Wyn Hornbuckle, a spokesperson for the U.S. Justice Division, stated in an announcement that he was upset within the consequence, however respects the jury’s determination and stays dedicated to imposing the antitrust legal guidelines within the labor markets.